FDA-Drug2026-10-14Class IIPROCESSING DEFECT
Apothecary NAD+ Injection recalled for lack of sterility assurance
What this means
Apothecary Pharma LLC is recalling one vial of Apothecary NAD+ Injection (200 mg/mL, 6 mL multi-dose vial, Lot #AP-202647) because the company cannot confirm the product meets sterility standards. A sterile injectable product that is not sterile poses a risk of infection if injected.
- If you have this vial (Lot #AP-202647, expiration 13-Oct-2026), do not use it.
- Contact your pharmacy or healthcare provider for guidance on obtaining a replacement or alternative treatment.
- Contact Apothecary Pharma LLC or the FDA if you have questions.
The agency's original wording
Hazard
Lack of Assurance of Sterility
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
1 vial
Manufactured in
1913 Evans Rd, N/A, Cary, NC, United States
Products
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0037-2027More Apothecary Pharma recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.